Chemistry:LY-293284

From HandWiki
Short description: Chemical compound
LY-293284
LY293284 structure.png
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
Chemical and physical data
FormulaC19H26N2O
Molar mass298.430 g·mol−1
3D model (JSmol)
  (verify)

LY-293284 is a research chemical developed by the pharmaceutical company Eli Lilly and used for scientific studies. It acts as a potent and selective 5-HT1A receptor full agonist. It was derived through structural simplification of the ergoline based psychedelic LSD,[1] but is far more selective for 5-HT1A with over 1000× selectivity over other serotonin receptor subtypes and other targets.[2] It has anxiogenic effects in animal studies.[3]

See also

References

  1. "Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity". Journal of Medicinal Chemistry 41 (12): 2134–45. June 1998. doi:10.1021/jm980076u. PMID 9622555. 
  2. "Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity". The Journal of Pharmacology and Experimental Therapeutics 270 (3): 1270–81. September 1994. PMID 7523657. 
  3. "Comparative effects of novel 5-HT1A receptor ligands, LY293284, LY315712 and LY297996, on plus-maze anxiety in mice". Psychopharmacology 139 (3): 185–94. October 1998. doi:10.1007/s002130050703. PMID 9784072.